In the current study, one of the largest in our knowledge to assess IGFR protein expression in early breast cancer, we found an overall moderate or strong expression of IGF1R-alpha in 54.4% of the whole patient population, which is consistent with previous studies reporting expression rates of 43.8% [12] to 87% [19]. This evidence concerns the gene IGF1R and breast carcinoma.